Michael Panzara
Net worth: - $ as of 2026-06-29
Net worth: - $ as of 2026-06-29
Michael A. Panzara is currently Director at Cadenza Bio, Inc., Independent Director at LeonaBio, Inc. since 2022, and Chief Medical Officer at Immunic, Inc. starting in 2026.
Formerly, Dr. Panzara was Director at Wave Life Sciences UK Ltd. from 2018 to 2022, Chief Medical Officer & Head-Therapeutics at Wave Life Sciences Ltd. from 2020 to 2022, Chief Medical Officer at Neurvati Neurosciences, Inc. from 2022 to 2026, Head-Multiple Sclerosis & Neurology at Genzyme Corp.
from 2009 to 2016, and Chief Medical Officer-Neurology & Vice President at Biogen, Inc. from 2001 to 2009.
Education includes an undergraduate degree from the University of Pennsylvania in 1989, a doctorate from Stanford University School of Medicine in 1994, and a graduate degree from Harvard T.H.
Chan School of Public Health in 2002.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LEONABIO, INC. -.--% | 2026-06-22 | 0 ( -.--% ) | - $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| LEONABIO, INC. | Director/Board Member | 2022-03-17 |
| IMMUNIC, INC. | Chief Tech/Sci/R&D Officer | 2026-04-23 |
| Companies | Position | End |
|---|---|---|
Neurvati Neurosciences, Inc.
Neurvati Neurosciences, Inc. BiotechnologyHealth Technology Develops therapies for neurological and psychiatric disorders | Chief Tech/Sci/R&D Officer | 2026-02-28 |
| WAVE LIFE SCIENCES LTD. | Chief Tech/Sci/R&D Officer | 2022-10-13 |
Wave Life Sciences UK Ltd.
Wave Life Sciences UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | 2021-12-31 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 2016-06-30 |
| BIOGEN INC. | Corporate Officer/Principal | 2009-08-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
LeonaBio, Inc.
LeonaBio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Wave Life Sciences Ltd.
Wave Life Sciences Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA oligonucleotides medicines | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard T.H. Chan School of Public Health
Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wave Life Sciences UK Ltd.
Wave Life Sciences UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Immunic, Inc.
Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
Neurvati Neurosciences, Inc.
Neurvati Neurosciences, Inc. BiotechnologyHealth Technology Develops therapies for neurological and psychiatric disorders | Health Technology |
Select your edition
All financial news and data tailored to specific country editions